Compass Therapeutics (CMPX) Assets: 2023-2025
Historic Assets for Compass Therapeutics (CMPX) over the last 3 years, with Sep 2025 value amounting to $231.3 million.
- Compass Therapeutics' Assets rose 55.05% to $231.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $231.3 million, marking a year-over-year increase of 55.05%. This contributed to the annual value of $140.4 million for FY2024, which is 10.50% down from last year.
- Per Compass Therapeutics' latest filing, its Assets stood at $231.3 million for Q3 2025, which was up 98.17% from $116.7 million recorded in Q2 2025.
- Compass Therapeutics' 5-year Assets high stood at $231.3 million for Q3 2025, and its period low was $116.7 million during Q2 2025.
- For the 3-year period, Compass Therapeutics' Assets averaged around $161.8 million, with its median value being $156.9 million (2023).
- Data for Compass Therapeutics' Assets shows a peak YoY increase of 55.05% (in 2025) and a maximum YoY decrease of 25.01% (in 2025) over the last 5 years.
- Quarterly analysis of 3 years shows Compass Therapeutics' Assets stood at $156.9 million in 2023, then dropped by 10.50% to $140.4 million in 2024, then soared by 55.05% to $231.3 million in 2025.
- Its Assets stands at $231.3 million for Q3 2025, versus $116.7 million for Q2 2025 and $131.5 million for Q1 2025.